NO20055884L - Asenanin for behandling av schizofreni hos en pasient med overvekt eller predisposisjon for overvekt - Google Patents
Asenanin for behandling av schizofreni hos en pasient med overvekt eller predisposisjon for overvektInfo
- Publication number
- NO20055884L NO20055884L NO20055884A NO20055884A NO20055884L NO 20055884 L NO20055884 L NO 20055884L NO 20055884 A NO20055884 A NO 20055884A NO 20055884 A NO20055884 A NO 20055884A NO 20055884 L NO20055884 L NO 20055884L
- Authority
- NO
- Norway
- Prior art keywords
- patient
- obesity
- overweight
- schizophrenia
- asenanine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Oppfinnelsen tilveiebringer metoder for behandling av schizofreni med et antipsykotisk middel administrert til en pasient med overvekt eller til en pasient som har vektøkning på grunn av et antipsykotisk middel eller til en pasient som trenger å bli beskyttet mot vektøkning på grunn av tilstedeværelse av risikofaktorer for en sykdom for hvilken overvekt også er en risikofaktor eller på grunn av tilstedeværelse av andre vektøkende faktorer ved anvendelse av asenapin for fremstilling av en medisin
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03101721 | 2003-06-12 | ||
PCT/EP2004/051069 WO2004110437A1 (en) | 2003-06-12 | 2004-06-09 | Asenapine for the treatment of schizophrenia in a patient with overweight or predisposition for overweight |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20055884L true NO20055884L (no) | 2006-01-03 |
Family
ID=33547705
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20055884A NO20055884L (no) | 2003-06-12 | 2005-12-12 | Asenanin for behandling av schizofreni hos en pasient med overvekt eller predisposisjon for overvekt |
Country Status (25)
Country | Link |
---|---|
US (1) | US20060128688A1 (no) |
EP (1) | EP1635820B1 (no) |
JP (1) | JP2006527238A (no) |
KR (1) | KR20060020664A (no) |
CN (1) | CN1816335A (no) |
AR (1) | AR044675A1 (no) |
AT (1) | ATE395914T1 (no) |
AU (1) | AU2004246820B2 (no) |
BR (1) | BRPI0411237A (no) |
CA (1) | CA2528365A1 (no) |
CY (1) | CY1110366T1 (no) |
DE (1) | DE602004013966D1 (no) |
DK (1) | DK1635820T3 (no) |
ES (1) | ES2305829T3 (no) |
HK (1) | HK1084894A1 (no) |
IL (1) | IL172397A (no) |
NO (1) | NO20055884L (no) |
NZ (1) | NZ544018A (no) |
PL (1) | PL1635820T3 (no) |
PT (1) | PT1635820E (no) |
RU (1) | RU2352336C2 (no) |
SI (1) | SI1635820T1 (no) |
TW (1) | TWI327915B (no) |
WO (1) | WO2004110437A1 (no) |
ZA (1) | ZA200509904B (no) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006106135A1 (en) * | 2005-04-07 | 2006-10-12 | N.V. Organon | Crystal form of asenapine maleate |
US7741358B2 (en) | 2005-04-14 | 2010-06-22 | N.V. Organon | Crystal form of asenapine maleate |
CA3047451A1 (en) | 2016-12-20 | 2018-06-28 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system containing asenapine |
JP7149287B2 (ja) * | 2016-12-20 | 2022-10-06 | エルテーエス ローマン テラピー-ジステーメ アーゲー | アセナピンおよびポリシロキサンまたはポリイソブチレンを含有する経皮治療システム |
EP3644973B1 (en) | 2017-06-26 | 2021-03-24 | LTS LOHMANN Therapie-Systeme AG | Transdermal therapeutic system containing asenapine and silicone acrylic hybrid polymer |
AU2019291060B2 (en) | 2018-06-20 | 2024-09-05 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system containing asenapine |
WO2020106330A1 (en) * | 2018-07-18 | 2020-05-28 | Pillsy, Inc. | Smart drug delivery and monitoring device, kit, and method of use for pill compounds |
CA3158745A1 (en) | 2019-12-11 | 2021-06-17 | Corcept Therapeutics Incorporated | Methods of treating antipsychotic-induced weight gain with miricorilant |
RU2756614C1 (ru) * | 2021-04-07 | 2021-10-04 | Федеральное государственное бюджетное научное учреждение «Томский национальный исследовательский медицинский центр Российской академии наук» (Томский НИМЦ) | Способ поддержки принятия врачебных решений выбора антипсихотической терапии у больных шизофренией с целью профилактики акатизии |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2182981C (en) * | 1994-03-02 | 2006-10-17 | Leonardus Petrus Carla Delbressine | Sublingual or buccal pharmaceutical composition |
US5496831A (en) * | 1994-05-13 | 1996-03-05 | The General Hospital Corporation | Inhibition of insulin-induced adiposis |
JP2004517112A (ja) * | 2001-01-02 | 2004-06-10 | ファルマシア・アンド・アップジョン・カンパニー | 新規薬物コンビネーション |
-
2004
- 2004-06-03 TW TW093116017A patent/TWI327915B/zh not_active IP Right Cessation
- 2004-06-09 NZ NZ544018A patent/NZ544018A/en not_active IP Right Cessation
- 2004-06-09 RU RU2006101061/14A patent/RU2352336C2/ru not_active IP Right Cessation
- 2004-06-09 AU AU2004246820A patent/AU2004246820B2/en not_active Ceased
- 2004-06-09 US US10/560,554 patent/US20060128688A1/en not_active Abandoned
- 2004-06-09 KR KR1020057023646A patent/KR20060020664A/ko not_active Application Discontinuation
- 2004-06-09 DK DK04766041T patent/DK1635820T3/da active
- 2004-06-09 BR BRPI0411237-7A patent/BRPI0411237A/pt not_active IP Right Cessation
- 2004-06-09 JP JP2006516141A patent/JP2006527238A/ja active Pending
- 2004-06-09 AT AT04766041T patent/ATE395914T1/de active
- 2004-06-09 CA CA002528365A patent/CA2528365A1/en not_active Abandoned
- 2004-06-09 DE DE602004013966T patent/DE602004013966D1/de not_active Expired - Lifetime
- 2004-06-09 WO PCT/EP2004/051069 patent/WO2004110437A1/en active IP Right Grant
- 2004-06-09 PT PT04766041T patent/PT1635820E/pt unknown
- 2004-06-09 SI SI200430755T patent/SI1635820T1/sl unknown
- 2004-06-09 ES ES04766041T patent/ES2305829T3/es not_active Expired - Lifetime
- 2004-06-09 CN CNA200480018591XA patent/CN1816335A/zh active Pending
- 2004-06-09 PL PL04766041T patent/PL1635820T3/pl unknown
- 2004-06-09 EP EP04766041A patent/EP1635820B1/en not_active Expired - Lifetime
- 2004-06-11 AR ARP040102026A patent/AR044675A1/es unknown
-
2005
- 2005-12-06 ZA ZA200509904A patent/ZA200509904B/en unknown
- 2005-12-06 IL IL172397A patent/IL172397A/en not_active IP Right Cessation
- 2005-12-12 NO NO20055884A patent/NO20055884L/no not_active Application Discontinuation
-
2006
- 2006-06-28 HK HK06107276A patent/HK1084894A1/xx not_active IP Right Cessation
-
2008
- 2008-06-24 CY CY20081100659T patent/CY1110366T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
RU2006101061A (ru) | 2006-07-27 |
IL172397A0 (en) | 2006-04-10 |
PL1635820T3 (pl) | 2008-10-31 |
DE602004013966D1 (de) | 2008-07-03 |
TWI327915B (en) | 2010-08-01 |
TW200501946A (en) | 2005-01-16 |
AU2004246820A1 (en) | 2004-12-23 |
KR20060020664A (ko) | 2006-03-06 |
EP1635820B1 (en) | 2008-05-21 |
CA2528365A1 (en) | 2004-12-23 |
CN1816335A (zh) | 2006-08-09 |
NZ544018A (en) | 2008-07-31 |
US20060128688A1 (en) | 2006-06-15 |
ES2305829T3 (es) | 2008-11-01 |
WO2004110437A1 (en) | 2004-12-23 |
SI1635820T1 (sl) | 2008-08-31 |
EP1635820A1 (en) | 2006-03-22 |
CY1110366T1 (el) | 2014-04-09 |
AU2004246820B2 (en) | 2009-10-01 |
ZA200509904B (en) | 2006-12-27 |
IL172397A (en) | 2010-06-16 |
ATE395914T1 (de) | 2008-06-15 |
JP2006527238A (ja) | 2006-11-30 |
DK1635820T3 (da) | 2008-09-08 |
PT1635820E (pt) | 2008-06-17 |
AR044675A1 (es) | 2005-09-21 |
HK1084894A1 (en) | 2006-08-11 |
RU2352336C2 (ru) | 2009-04-20 |
BRPI0411237A (pt) | 2006-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20055884L (no) | Asenanin for behandling av schizofreni hos en pasient med overvekt eller predisposisjon for overvekt | |
WO2007053661A3 (en) | Uses of anti-cd40 antibodies | |
NO20070247L (no) | Amino-5,5-difenylimidazolonderivater for inhibisjon av beta-sekretase | |
CO6390109A2 (es) | Inhibidores de syk de imidazopirazina | |
NO20074999L (no) | Metode og preparat for behandling av perifere vaskulaere sykdommer | |
WO2009039397A3 (en) | Substituted amides, methods of making, use thereof for the treatment of diseases such as cancer | |
UY32177A (es) | Tratamiento de diabetes en pacientes con control glucémico insuficiente a pesar de la terapia con fármaco, oral o no, antidiabético | |
NO20065847L (no) | Difenylimidazopyrimidiner og -imidazolaminer som inhibitorer av B-sekretase | |
SG170101A1 (en) | 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial. | |
EP2331095A4 (en) | CYNURENINE-3-MONOOXYGENASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND METHOD OF USE THEREOF | |
WO2010029089A3 (en) | Combination therapy for the treatment of diabetes and related conditions | |
MA28935B1 (fr) | Preparation et utilisation de derives de biphenyl-4-yl-carbonylamino-acide dans le traitement de l'obesite | |
AU2012286851A8 (en) | Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof | |
MA32611B1 (fr) | Procedes de traitement de la thalassemie | |
DK1915620T3 (da) | Diagnose, behandling og prævention af vaskulære sygdomme ved hjælp af IL-1alpha-autoantistoffer | |
NO20083036L (no) | Anvendelse av benzofuserte heterocykliske sulfamidderivater for behandling av depresjon | |
NO20084749L (no) | Organiske forbindelser og deres anvendelser | |
DK1973541T3 (da) | Anvendelse af benzokondenserede heterocykliske sulfamidderivater til nedsættelse af lipid- og blodglucoseniveauer | |
ATE456955T1 (de) | Verwendung von cyclodextrin zur behandlung und vorbeugung von entzündlichen bronchialerkrankungen | |
WO2009068659A3 (en) | Novel disease treatment by predicting drug association | |
NO20083004L (no) | Anvendelse av benzofuserte heterocykliske sulfamidderivater for behandling av stoffmisbrukavhengighet | |
BRPI0921097B8 (pt) | composto ou seu sal farmaceuticamente aceitável, intermediário do composto, composição farmacêutica e uso do composto | |
WO2007023072A3 (en) | Use of ambroxol for the treatment of rhinovirus infections | |
MA46268A (fr) | Dérivés de 5-[2-(pyridin-2-ylamino)-1,3-thiazol-5-yl]-2,3-dihydro-1h-isoindol-1-one et leur utilisation en tant qu'inhibiteurs doubles de phosphatidylinositol 3-kinase delta & gamma | |
DE602007011434D1 (de) | 1h-indol-5-ylpiperazin-1-ylmethanonderivate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |